Company intelligence / Profile preview
SOCIUM
Japansocium.co.jp ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SOCIUM is a Japanese biotech company focused on discovering drugs for patients with no available or ineffective treatments. Their lead candidate, SO-002, is being evaluated in an investigator-led clinical trial for ALS. The company has published research and filed patents related to their drug candidates and proprietary phosphorylation analysis platform.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculePeptides
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Nanjing Medical UniversityHuaxi Hospital of Sichuan University
Beyond the preview
Go deeper on SOCIUM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOCIUM.